EG21417A - Process for preparing of hydrate of 5-(4 (2(n-methyl n-(2-pyridyl) amino) ethoxy) thiazolidine-2,4- dione maleic acid salt - Google Patents
Process for preparing of hydrate of 5-(4 (2(n-methyl n-(2-pyridyl) amino) ethoxy) thiazolidine-2,4- dione maleic acid saltInfo
- Publication number
- EG21417A EG21417A EG155498A EG155498A EG21417A EG 21417 A EG21417 A EG 21417A EG 155498 A EG155498 A EG 155498A EG 155498 A EG155498 A EG 155498A EG 21417 A EG21417 A EG 21417A
- Authority
- EG
- Egypt
- Prior art keywords
- thiazolidine
- pyridyl
- hydrate
- ethoxy
- amino
- Prior art date
Links
- VJYJKNKXBSOHFP-ODZAUARKSA-N (Z)-but-2-enedioic acid 1,3-thiazolidine-2,4-dione Chemical compound O=C1CSC(=O)N1.OC(=O)\C=C/C(O)=O VJYJKNKXBSOHFP-ODZAUARKSA-N 0.000 title 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9726568.0A GB9726568D0 (en) | 1997-12-16 | 1997-12-16 | Novel pharmaceutical |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EG21417A true EG21417A (en) | 2001-10-31 |
Family
ID=10823694
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EG155498A EG21417A (en) | 1997-12-16 | 1998-12-15 | Process for preparing of hydrate of 5-(4 (2(n-methyl n-(2-pyridyl) amino) ethoxy) thiazolidine-2,4- dione maleic acid salt |
| EG155098A EG23694A (en) | 1997-12-16 | 1998-12-15 | Novel pharmaceutical |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EG155098A EG23694A (en) | 1997-12-16 | 1998-12-15 | Novel pharmaceutical |
Country Status (37)
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9909041D0 (en) * | 1999-04-20 | 1999-06-16 | Smithkline Beecham Plc | Novel pharmaceutical |
| US20040248945A1 (en) | 1999-04-23 | 2004-12-09 | Smithkline Beecham P.L.C. | Thiazolidinedione derivative and its use as antidiabetic |
| HRP20010773B1 (en) | 1999-04-23 | 2005-06-30 | Smithkline Beecham P.L.C. | Thiazolidinedione derivative and its use as antidiabetic |
| CZ20013801A3 (cs) * | 1999-04-23 | 2002-07-17 | Smithkline Beecham Plc | Nový léčivý přípravek |
| GB0014005D0 (en) * | 2000-06-08 | 2000-08-02 | Smithkline Beecham Plc | Novel pharmaceutical |
| GB0021784D0 (en) * | 2000-09-05 | 2000-10-18 | Smithkline Beecham Plc | Novel pharmaceutical |
| GB0021978D0 (en) * | 2000-09-07 | 2000-10-25 | Smithkline Beecham Plc | Novel pharmaceutical |
| AU2002352391A1 (en) * | 2001-12-13 | 2003-06-23 | Smithkline Beecham Plc | A 5(-4-(2-(n-methyl-n-(2-pyridil)amino)ethoxy)benzyl)thiazolidine-2,4-dione (i) 10-camphorsulphonic acid salt and use against diabetes mellitus |
| GB0129876D0 (en) * | 2001-12-13 | 2002-02-06 | Smithkline Beecham Plc | Novel pharmaceutical |
| WO2003050112A1 (en) * | 2001-12-13 | 2003-06-19 | Smithkline Beecham Plc | Toluenesulfonate hydrates of a thiazolidinedione derivative |
| WO2003053962A1 (en) * | 2001-12-20 | 2003-07-03 | Smithkline Beecham Plc | 5- (4- (2- (n-methyl-n- (2-pyridyl) amino) ethoxy) benzyl) thiazolidine-2, 4-dione malic acid salt and use against diabetes mellitus |
| GB0130511D0 (en) * | 2001-12-20 | 2002-02-06 | Smithkline Beecham Plc | Novel pharmaceutical |
| GB2405403A (en) * | 2003-08-29 | 2005-03-02 | Cipla Ltd | Rosiglitazone maleate of particular polymorphic forms and methods of preparing rosiglitazone free base |
| ITMI20041537A1 (it) * | 2004-07-28 | 2004-10-28 | Chemi Spa | Nuova forma polimorfa del rosiglitazone maleato |
| CZ298424B6 (cs) * | 2005-05-24 | 2007-09-26 | Zentiva, A. S. | Zpusob krystalizace rosiglitazonu a jeho derivátuze smesných rozpouštedel |
| EP2184055A1 (en) | 2008-11-07 | 2010-05-12 | LEK Pharmaceuticals d.d. | Process for preparing solid dosage forms of rosiglitazone maleate |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR240698A1 (es) * | 1985-01-19 | 1990-09-28 | Takeda Chemical Industries Ltd | Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales |
| US4812570A (en) * | 1986-07-24 | 1989-03-14 | Takeda Chemical Industries, Ltd. | Method for producing thiazolidinedione derivatives |
| ATE186724T1 (de) * | 1987-09-04 | 1999-12-15 | Beecham Group Plc | Substituierte thiazolidindionderivate |
| GB8820389D0 (en) * | 1988-08-26 | 1988-09-28 | Beecham Group Plc | Novel compounds |
| GB9124513D0 (en) | 1991-11-19 | 1992-01-08 | Smithkline Beecham Plc | Novel process |
| AU5082993A (en) | 1992-08-28 | 1994-03-29 | Merck & Co., Inc. | Cationic-2-heteroarylphenyl-carbapenem antibacterial agents |
| GB9218830D0 (en) | 1992-09-05 | 1992-10-21 | Smithkline Beecham Plc | Novel compounds |
| US5741803A (en) | 1992-09-05 | 1998-04-21 | Smithkline Beecham Plc | Substituted thiazolidinedionle derivatives |
| TW245716B (enExample) * | 1992-12-28 | 1995-04-21 | Takeda Pharm Industry Co | |
| DE4404198A1 (de) | 1994-02-10 | 1995-08-17 | Henkel Kgaa | 2-Fluor-6-nitroaniline |
| GB9726566D0 (en) | 1997-12-16 | 1998-02-11 | Smithkline Beecham Plc | Novel pharmaceutical |
| US20020137940A1 (en) | 1997-12-16 | 2002-09-26 | Smithkline Beecham P.L.C. | 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical |
| GB9726563D0 (en) | 1997-12-16 | 1998-02-11 | Smithkline Beecham Plc | Novel pharmaceutical |
| US6664278B2 (en) * | 1997-12-16 | 2003-12-16 | Smithkline Beecham P.L.C. | Hydrate of 5-[4-[2-(N-methyl-N-(2-pyridil)amino)ethoxy]benzyl]thiazolidine-2,4-dione maleic acid salt |
| CZ432299A3 (cs) * | 1998-06-02 | 2000-08-16 | Smithkline Beecham Plc | Kompozice obsahující 5-[4-[2-(N-methyl-N-(2- pyridyI)amino)ethoxy]benzyl]thiazolidin-2,4-dion |
| AR023561A1 (es) | 1999-04-23 | 2002-09-04 | Smithkline Beecham Corp | Una forma polimorfica del acido maleico de un derivado de tiazolidin-2, 4 diona, una composicion farmaceutica y el uso de dicho polimorfo para lafabricacion de un medicamento |
| CZ20013801A3 (cs) | 1999-04-23 | 2002-07-17 | Smithkline Beecham Plc | Nový léčivý přípravek |
| HRP20010773B1 (en) | 1999-04-23 | 2005-06-30 | Smithkline Beecham P.L.C. | Thiazolidinedione derivative and its use as antidiabetic |
-
1997
- 1997-12-16 GB GBGB9726568.0A patent/GB9726568D0/en not_active Ceased
-
1998
- 1998-12-14 CN CNA2008100930575A patent/CN101412714A/zh active Pending
- 1998-12-14 KR KR1020007006517A patent/KR100549143B1/ko not_active Expired - Fee Related
- 1998-12-14 NZ NZ504704A patent/NZ504704A/xx unknown
- 1998-12-14 CZ CZ20002205A patent/CZ299970B6/cs not_active IP Right Cessation
- 1998-12-14 WO PCT/EP1998/008154 patent/WO1999031094A1/en not_active Ceased
- 1998-12-14 TR TR2000/01798T patent/TR200001798T2/xx unknown
- 1998-12-14 CN CNA2008100930560A patent/CN101412713A/zh active Pending
- 1998-12-14 UA UA2000063484A patent/UA63980C2/uk unknown
- 1998-12-14 PL PL98341147A patent/PL341147A1/xx not_active Application Discontinuation
- 1998-12-14 CN CN98812092A patent/CN1281454A/zh active Pending
- 1998-12-14 AU AU22723/99A patent/AU2272399A/en not_active Abandoned
- 1998-12-14 SK SK910-2000A patent/SK286197B6/sk not_active IP Right Cessation
- 1998-12-14 MA MA25392A patent/MA26582A1/fr unknown
- 1998-12-14 RS YUP-362/00A patent/RS50079B/sr unknown
- 1998-12-14 HR HR20000405A patent/HRP20000405A2/hr not_active Application Discontinuation
- 1998-12-14 JP JP2000539018A patent/JP2002508372A/ja not_active Withdrawn
- 1998-12-14 CA CA002314965A patent/CA2314965A1/en not_active Abandoned
- 1998-12-14 HU HU0100500A patent/HUP0100500A3/hu unknown
- 1998-12-14 OA OA1200000179A patent/OA11634A/en unknown
- 1998-12-14 IL IL13638198A patent/IL136381A/xx unknown
- 1998-12-14 AP APAP/P/2000/001830A patent/AP1441A/en active
- 1998-12-14 EA EA200000655A patent/EA002355B1/ru not_active IP Right Cessation
- 1998-12-14 BR BR9813604-6A patent/BR9813604A/pt not_active Application Discontinuation
- 1998-12-14 ID IDW20001126A patent/ID24744A/id unknown
- 1998-12-14 EP EP98966321A patent/EP1045847A1/en not_active Ceased
- 1998-12-15 EG EG155498A patent/EG21417A/xx active
- 1998-12-15 EG EG155098A patent/EG23694A/xx active
- 1998-12-15 ZA ZA9811505A patent/ZA9811505B/xx unknown
- 1998-12-15 UY UY25305A patent/UY25305A1/es not_active IP Right Cessation
- 1998-12-15 DZ DZ980290A patent/DZ2680A1/xx active
- 1998-12-15 AR ARP980106365A patent/AR017430A1/es not_active Application Discontinuation
- 1998-12-15 UY UY25310A patent/UY25310A1/es not_active IP Right Cessation
- 1998-12-15 AR ARP980106369A patent/AR017213A1/es not_active Application Discontinuation
- 1998-12-15 MY MYPI98005675A patent/MY135770A/en unknown
- 1998-12-16 CO CO98074830A patent/CO4990927A1/es unknown
- 1998-12-16 PE PE1998001232A patent/PE20000057A1/es not_active Application Discontinuation
- 1998-12-16 TR TR1998/02626A patent/TR199802626A3/tr unknown
- 1998-12-16 IN IN3770DE1998 patent/IN190821B/en unknown
- 1998-12-16 TW TW087121122A patent/TW467913B/zh not_active IP Right Cessation
-
2000
- 2000-06-15 NO NO20003068A patent/NO317253B1/no not_active IP Right Cessation
- 2000-07-11 BG BG104595A patent/BG64905B1/bg unknown
-
2003
- 2003-10-24 US US10/692,544 patent/US7045633B2/en not_active Expired - Fee Related
-
2006
- 2006-03-16 US US11/377,470 patent/US20060189659A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO2001005I2 (no) | 5-Ä4-Ä2-(N-metyl-N-(2-pyridyl)amino)etoksy)benzyl)tiazolidin-2,4dion, maleinsyresalt | |
| NZ504703A (en) | Substituted thiazolidinedione derivative, process for its preparation and its pharmaceutical use | |
| HUP0100509A3 (en) | 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl] thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical, process for its preparation and its pharmaceutical use | |
| PL351684A1 (en) | Polymorph of 5−[4−[2− (n−methyl−n−( 2−pyridyl)amino) ethoxy]benzyl] thiazolidine−2,4−dione, maleic acid salt | |
| AP2000001830A0 (en) | Hydrate of 5-[4-[2-(n-methyl-n-(2-pyridil)amino)ethoxy]benzyl]thiazolidine-2,4-dione maleic acid salt | |
| BG106119A (en) | Thiazolidine derivative and its use as antidiabetic means | |
| MY129475A (en) | Process for the preparation of substituted thiazolidinedione | |
| WO2000063205A3 (en) | Thiazolidinedione derivative and its use as antidiabetic | |
| WO2000063206A3 (en) | Thiazolidinedione derivative and its use as antidiabetic | |
| SI1315723T1 (en) | The hydrochloride salt of 5(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyl)thiazolidine-2,4-dione | |
| HU0700069D0 (en) | Acid addition salts of 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione different from malei acid salt | |
| HK1032905A (en) | 5-[4-[2-(n-methyl-n-(2-pyridyl)amino) ethoxy]benzyl] thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical | |
| HK1032955A (en) | Hydrate of 5-[4-[2- (n-methyl-n- (2-pyridil)amino) ethoxy]benzyl] thiazolidine-2, 4-dione maleic acid salt | |
| SI1173435T1 (en) | Polymorph of 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyl)thiazolidine-2,4-dione maleic acid salt | |
| HK1057209A (en) | Novel polymorphic forms of 5-[4-[2-[n-methyl-n-(2-pyridyl)amino]ethoxy]benz yl]thiazolidine-2,4-dione maleic acid salt and process for their preparation | |
| NO20012028D0 (no) | Fremgangsmåte for fremstilling av 4-((2',5'-diamino-6'- halogenpyrimidin-4'-yl)amino)-cyclopent-2-enyl-metanoler |